• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罪犯血管慢性完全闭塞对梗死相关心原性休克的预后影响:IABP-SHOCK II 随机试验的结果。

Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial.

机构信息

Medical Clinic II, University Heart Center Lübeck, Lübeck.

出版信息

EuroIntervention. 2018 Jun 8;14(3):e306-e313. doi: 10.4244/EIJ-D-17-00451.

DOI:10.4244/EIJ-D-17-00451
PMID:29205158
Abstract

AIMS

The aim of the current study was to investigate the impact of a chronic total occlusion (CTO) in a non-infarct-related coronary artery (non-IRA) on one-year mortality and occurrence of cardiac arrhythmia in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI).

METHODS AND RESULTS

In a retrospective sub-analysis of the Intraaortic Balloon Pump in Cardiogenic Shock II trial (IABP-SHOCK II) and its accompanying registry, 201 (26%) of 761 patients had a CTO in a non-IR major coronary artery. Mortality was significantly higher in the CTO group at day of admission (19% vs. 11%; p=0.005), 30 days (53% vs. 41%, p=0.002), and 12 months (63% vs. 51%, p=0.002). In the adjusted multivariate Cox regression analysis, a CTO in a non-IRA was an independent predictor of mortality at 12 months (hazard ratio 1.30, 95% confidence interval [CI]: 1.02-1.67, p=0.03). At 30-day follow-up, ventricular arrhythmias requiring defibrillation occurred more frequently in patients with non-IRA CTO in the univariate analysis (33% vs. 21%, odds ratio 1.83, 95% CI: 1.28-2.62, p=0.002).

CONCLUSIONS

In patients with CS complicating AMI, the presence of CTO in a non-IRA is associated with a higher incidence of ventricular arrhythmias and is an independent predictor of mortality at 12-month follow-up.

摘要

目的

本研究旨在探讨非梗死相关冠状动脉(非 IRA)慢性完全闭塞(CTO)对合并急性心肌梗死(AMI)所致心源性休克(CS)患者一年死亡率和心律失常发生的影响。

方法和结果

在主动脉内球囊泵治疗心源性休克 II 试验(IABP-SHOCK II)及其伴随的登记研究的回顾性亚分析中,761 例患者中有 201 例(26%)非 IRA 主要冠状动脉存在 CTO。入院当天(19% vs. 11%;p=0.005)、第 30 天(53% vs. 41%,p=0.002)和第 12 个月(63% vs. 51%,p=0.002)时,CTO 组的死亡率明显更高。在调整后的多变量 Cox 回归分析中,非 IRA 中的 CTO 是 12 个月时死亡的独立预测因素(危险比 1.30,95%置信区间 [CI]:1.02-1.67,p=0.03)。在第 30 天随访时,在单变量分析中,非 IRA CTO 患者更频繁发生需要除颤的室性心律失常(33% vs. 21%,优势比 1.83,95%CI:1.28-2.62,p=0.002)。

结论

在合并 AMI 的 CS 患者中,非 IRA 中的 CTO 与更高的室性心律失常发生率相关,是 12 个月随访时死亡的独立预测因素。

相似文献

1
Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial.罪犯血管慢性完全闭塞对梗死相关心原性休克的预后影响:IABP-SHOCK II 随机试验的结果。
EuroIntervention. 2018 Jun 8;14(3):e306-e313. doi: 10.4244/EIJ-D-17-00451.
2
Chronic total occlusion in non-infarct-related artery is associated with increased short-and long-term mortality in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock (from the CREDO-Kyoto AMI registry).非梗死相关动脉的慢性完全闭塞与 ST 段抬高型急性心肌梗死合并心原性休克患者的短期和长期死亡率增加相关(来自 CREDO-Kyoto AMI 注册研究)。
Catheter Cardiovasc Interv. 2018 Sep 1;92(3):455-463. doi: 10.1002/ccd.27330. Epub 2017 Sep 30.
3
Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.心肌梗死合并心源性休克患者的罪犯病变部位与预后:IABP-SHOCK II试验的一项子研究
Clin Res Cardiol. 2016 Dec;105(12):1030-1041. doi: 10.1007/s00392-016-1017-6. Epub 2016 Jul 4.
4
Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial.编辑精选-急性心肌梗死并发心原性休克患者行即刻多支血管经皮冠状动脉介入治疗与罪犯病变介入治疗对 1 年预后的影响:随机 IABP-SHOCK II 试验结果。
Eur Heart J Acute Cardiovasc Care. 2017 Oct;6(7):601-609. doi: 10.1177/2048872616668977. Epub 2016 Sep 21.
5
[Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].[主动脉反搏治疗心源性休克患者的短期和中期临床结局]
G Ital Cardiol. 1996 Dec;26(12):1385-99.
6
"Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry.心肌梗死并发心源性休克患者中的“吸烟者悖论”——IABP-SHOCK II试验及注册研究的一项子研究
Int J Cardiol. 2016 Nov 1;222:775-779. doi: 10.1016/j.ijcard.2016.07.172. Epub 2016 Jul 29.
7
Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial [corrected].急性心肌梗死合并心原性休克患者基线血糖水平对预后的影响——IABP-SHOCK II 试验的亚研究[已更正]。
Clin Res Cardiol. 2018 Jun;107(6):517-523. doi: 10.1007/s00392-018-1213-7. Epub 2018 Feb 8.
8
Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.接受直接经皮冠状动脉介入治疗和主动脉内球囊反搏的心源性休克患者的死亡率预测因素。
Med Klin Intensivmed Notfmed. 2016 Nov;111(8):715-722. doi: 10.1007/s00063-015-0118-8. Epub 2015 Nov 23.
9
Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial.梗死相关心原性休克患者慢性完全闭塞和血运重建策略的影响:罪犯-休克试验的亚组分析。
Am Heart J. 2021 Feb;232:185-193. doi: 10.1016/j.ahj.2020.11.009. Epub 2020 Nov 27.
10
Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.急性心肌梗死合并心源性休克时的成纤维细胞生长因子23:心源性休克主动脉内球囊反搏II(IABP-SHOCK II)试验的生物标志物子研究
Crit Care. 2014 Dec 21;18(6):713. doi: 10.1186/s13054-014-0713-8.

引用本文的文献

1
The role of chronic total occlusions in non-infarct-related arteries in acute coronary syndrome patients: a systematic review.急性冠状动脉综合征患者非梗死相关动脉中慢性完全闭塞的作用:系统评价。
Future Cardiol. 2024;20(10):581-590. doi: 10.1080/14796678.2024.2406651. Epub 2024 Oct 9.
2
Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.心源性休克幸存者的最佳心力衰竭药物治疗与死亡率:来自 FRENSHOCK 注册研究的见解。
J Am Heart Assoc. 2024 Mar 5;13(5):e030975. doi: 10.1161/JAHA.123.030975. Epub 2024 Feb 23.
3
Long-Term Outcomes in Patients With Chronic Total Occlusion.
慢性完全闭塞患者的长期结局。
Am J Cardiol. 2024 Mar 1;214:59-65. doi: 10.1016/j.amjcard.2023.12.052. Epub 2024 Jan 7.
4
The long-term impact of a chronic total occlusion in a non-infarct-related artery on acute ST-segment elevation myocardial infarction after primary coronary intervention.非梗死相关动脉慢性完全闭塞对经皮冠状动脉介入治疗后急性 ST 段抬高型心肌梗死的长期影响。
BMC Cardiovasc Disord. 2021 Jan 30;21(1):59. doi: 10.1186/s12872-021-01874-1.
5
Prognostic Impact of Percutaneous Coronary Intervention of Chronic Total Occlusion in Acute and Periprocedural Myocardial Infarction.慢性完全闭塞病变经皮冠状动脉介入治疗对急性及围手术期心肌梗死的预后影响
J Clin Med. 2021 Jan 12;10(2):258. doi: 10.3390/jcm10020258.
6
Temporary Mechanical Circulatory Support in Acute Heart Failure.急性心力衰竭中的临时机械循环支持
Card Fail Rev. 2020 Mar 16;6:e01. doi: 10.15420/cfr.2019.02. eCollection 2020 Mar.
7
Contemporary prevalence, trends, and outcomes of coronary chronic total occlusions in acute myocardial infarction with cardiogenic shock.急性心肌梗死合并心源性休克患者冠状动脉慢性完全闭塞的当代患病率、趋势及转归
Int J Cardiol Heart Vasc. 2019 Aug 29;24:100414. doi: 10.1016/j.ijcha.2019.100414. eCollection 2019 Sep.
8
Update in the Management of Acute Coronary Syndrome Patients with Cardiogenic Shock.急性冠脉综合征合并心原性休克患者的管理进展。
Curr Cardiol Rep. 2019 Mar 4;21(4):17. doi: 10.1007/s11886-019-1102-3.